STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
180
13F, latest reported quarter
Conversions, 180 days
4
Codes C/M, not in net · $0 priced
What the filings say about CXT
Insiders, 180 days
+$1.2M net bought
2 buyers
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-08-31
Crane NXT insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Crane NXT, Co. insiders bought a net $1.2M of stock across 15 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 37.2% of the 64,595 shares held after it.
1 other insider bought within 30 days.
180 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO Saak Aaron W bought about $1.0M of CXT on Jun 12, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 180 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 24.2% of the 14,663 shares held after it.
1 other insider bought within 30 days.
180 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Chief Financial Officer Cristiano Christina bought about $149.0K of CXT on Jun 12, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 180 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 0.3% of the 3,913 shares held after it.
No other insider bought within 30 days.
180 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, General Counsel & Sec. Igoe Paul Gerard bought about $641 of CXT on Mar 12, 2025, the largest insider purchase at the company since 2023; 180 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CXT planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CXT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
SouthernSun Small Cap Fund
$14.5M position · as of 2026-06-30
5.7%
SouthernSun U.S. Equity Fund
$2.5M position · as of 2026-06-30
5.1%
ICON HEALTH AND INFORMATION TECHNOLOGY FUND
$3.9M position · as of 2026-06-30
4.0%
Victory RS Investors Fund
$2.5M position · as of 2026-06-30
3.6%
LVIP Channing Small Cap Value Fund
$3.4M position · as of 2026-06-30
2.9%
CHANNING INTRINSIC VALUE SMALL-CAP FUND
$301.7K position · as of 2026-07-31
2.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr Mitchell
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2022
$9.3M
$10.8M
$2.4M
+24%
+33%
2021
$9.5M
$13.9M
$2.2M
+23%
+50%
2020
$6.4M
$2.4M
$1.6M
-8%
+18%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $1.2M bought by insiders over 180 days, 180 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.8B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CXT
FY Dec 2025
$1.7B
FY Dec 2024
$1.5B
FY Dec 2023
n/a
FY Dec 2022
$3.4B
FY Dec 2021
n/a
Jun 2026
$493.2M
Mar 2026
$387.7M
Dec 2025
$476.9M
Sep 2025
$445.1M
Jun 2025
$404.4M
Mar 2025
$330.3M
Dec 2024
$399.1M
Sep 2024
$403.5M
At each fiscal year end
Single quarter
Net margin, TTM
+7.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CXT
FY Dec 2025
+8.8%
FY Dec 2024
+12.4%
FY Dec 2023
n/a
FY Dec 2022
+6.1%
FY Dec 2021
n/a
Jun 2026
+7.2%
Mar 2026
+1.7%
Dec 2025
+10.1%
Sep 2025
+11.3%
Jun 2025
+6.2%
Mar 2025
+6.6%
Dec 2024
+14.4%
Sep 2024
+11.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$224.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CXT
FY Dec 2025
$198.3M
FY Dec 2024
$168.7M
FY Dec 2023
$245.2M
FY Dec 2022
$284.7M
FY Dec 2021
$258.4M
Jun 2026
$73.4M
Mar 2026
-$24.1M
Dec 2025
$96.0M
Sep 2025
$78.7M
Jun 2025
$55.8M
Mar 2025
-$32.2M
Dec 2024
$70.3M
Sep 2024
$53.5M
At each fiscal year end
Single quarter
Debt to equity
1.15x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity CXT
FY Dec 2025
0.91x
FY Dec 2024
0.70x
FY Dec 2023
0.67x
FY Dec 2022
1.08x
FY Dec 2021
1.10x
Jun 2026
1.15x
Mar 2026
1.22x
Dec 2025
0.91x
Sep 2025
0.89x
Jun 2025
0.96x
Mar 2025
0.73x
Dec 2024
0.70x
Sep 2024
0.74x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.19x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt CXT
FY Dec 2025
0.21x
FY Dec 2024
0.29x
FY Dec 2023
0.43x
FY Dec 2022
0.36x
FY Dec 2021
0.33x
Jun 2026
0.19x
Mar 2026
0.16x
Dec 2025
0.21x
Sep 2025
0.20x
Jun 2025
0.17x
Mar 2025
0.23x
Dec 2024
0.29x
Sep 2024
0.27x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+11.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CXT
FY Dec 2025
+12.5%
FY Dec 2024
+18.1%
FY Dec 2023
+21.5%
FY Dec 2022
+26.5%
FY Dec 2021
n/a
Jun 2026
+11.5%
Mar 2026
+11.1%
Dec 2025
+12.5%
Sep 2025
+13.5%
Jun 2025
+14.0%
Mar 2025
+16.2%
Dec 2024
+18.1%
Sep 2024
+18.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CXT
FY Dec 2025
+5.3%
FY Dec 2024
+8.2%
FY Dec 2023
+8.8%
FY Dec 2022
+6.2%
FY Dec 2021
n/a
Jun 2026
+4.3%
Mar 2026
+4.3%
Dec 2025
+5.3%
Sep 2025
+5.8%
Jun 2025
+5.7%
Mar 2025
+7.4%
Dec 2024
+8.2%
Sep 2024
+7.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+8.1%
operating income after a 20.2% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CXT
FY Dec 2025
+9.4%
FY Dec 2024
+13.9%
FY Dec 2023
+17.5%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+8.1%
Mar 2026
+7.5%
Dec 2025
+9.4%
Sep 2025
+9.6%
Jun 2025
+9.2%
Mar 2025
+12.3%
Dec 2024
+13.9%
Sep 2024
+13.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CXT
FY Dec 2025
+11.3%
FY Dec 2024
+14.9%
FY Dec 2023
+17.4%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+9.7%
Mar 2026
+9.8%
Dec 2025
+11.3%
Sep 2025
+11.2%
Jun 2025
+11.1%
Mar 2025
+13.7%
Dec 2024
+14.9%
Sep 2024
+14.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
23.63x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CXT
FY Dec 2025
18.83x
FY Dec 2024
18.25x
FY Dec 2023
17.34x
FY Dec 2022
7.67x
FY Dec 2021
4.81x
Jun 2026
21.23x
Mar 2026
18.20x
Dec 2025
18.83x
Sep 2025
25.03x
Jun 2025
20.57x
Mar 2025
17.66x
Dec 2024
18.25x
Sep 2024
18.39x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$4.5B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value CXT
FY Dec 2025
$3.6B
FY Dec 2024
$3.9B
FY Dec 2023
$3.6B
FY Dec 2022
$2.6B
FY Dec 2021
$2.4B
Jun 2026
$4.2B
Mar 2026
$3.6B
Dec 2025
$3.6B
Sep 2025
$4.8B
Jun 2025
$4.1B
Mar 2025
$3.6B
Dec 2024
$3.9B
Sep 2024
$3.8B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield CXT
FY Dec 2025
+7.3%
FY Dec 2024
+5.1%
FY Dec 2023
+7.6%
FY Dec 2022
+14.5%
FY Dec 2021
+12.5%
Jun 2026
+7.6%
Mar 2026
+8.9%
Dec 2025
+7.3%
Sep 2025
+4.5%
Jun 2025
+4.8%
Mar 2025
+4.7%
Dec 2024
+5.1%
Sep 2024
+5.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -8%, PEG needs growth
PEG, trailing CXT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.03x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CXT ranks highest on insider conviction (92nd percentile) and growth (71st), and lowest on financial health (25th), among Industrials peers.
Profitability
51
Inputs
Return on equity+11.5% · 58 pct, sector of 198
Return on assets+4.3% · 52 pct, sector of 224
Return on invested capital+8.1% · 30 pct, sector of 107
Return on capital employed+9.7% · 62 pct, sector of 195
Financial health
25
Inputs
Debt to equity1.15x · 13 pct, sector of 214
Cash flow to debt0.19x · 37 pct, sector of 173
Growth
71
Inputs
Revenue growth, YoY+11.4% · 69 pct, sector of 254
Backlog growth, YoY+27.7% · 74 pct, sector of 89
Insider conviction
92
Inputs
Net Form 4 buying (codes P and S), 180d$1.2M · 98 pct, sector of 170
Insider buyers, 180d2 · 86 pct, sector of 172
Institutional and government
33
Inputs
Funds adding, latest quarter180 · 56 pct, sector of 201
Congress net buyers, 365d-1 · 10 pct, sector of 43
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
44
Inputs
Short interest, % of float+15.9% · 9 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+20.0% · 22 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CXT filings, in plain words
Are Crane NXT insiders buying or selling CXT?
In the 180 days to 2026-10-28, Crane NXT insiders were net buyers, a net $1.2M across purchases and sales reported on Form 4, by 2 buyers.
Have members of Congress traded CXT?
Yes. In the year to 2026-10-28, 0 House members disclosed buying CXT and 1 House member disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-31.
Read the full summary
In the 180 days to 2026-10-28, Crane NXT insiders were net buyers of CXT, a net $1.2M across purchases and sales reported on Form 4 by 2 buyers. In the year to 2026-10-28, 0 members of Congress disclosed buying CXT and 1 member disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-31. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.